Patents by Inventor Wesley Loren Cosand

Wesley Loren Cosand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030211117
    Abstract: Novel peptides are provided having substantially the same sequence as immunologically significant fragments of AIDS-related viruses. The polypeptides can be used as reagents in the determination of exposure of a human host to the virus. Of particular interest is the use of polypeptides in screening blood products.
    Type: Application
    Filed: November 26, 2002
    Publication date: November 13, 2003
    Inventor: Wesley Loren Cosand
  • Patent number: 6485900
    Abstract: Novel peptides are provided having substantially the same sequence as immunologically significant fragments of AIDS-related viruses. The polypeptides can be used as reagents in the determination of exposure of a human host to the virus. Of particular interest is the use of polypeptides in screening blood products.
    Type: Grant
    Filed: June 20, 1990
    Date of Patent: November 26, 2002
    Assignee: Bio-Rad Laboratories
    Inventor: Wesley Loren Cosand
  • Patent number: 6214539
    Abstract: Novel peptides are provided having substantially the same sequence as immunologically significant fragments of AIDS-related viruses. The polypeptides can be used as reagents in the determination of exposure of a human host to the virus. Of particular interest is the use of polypeptides in screening blood products.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: April 10, 2001
    Assignee: Bio-Rad Laboratories
    Inventor: Wesley Loren Cosand
  • Patent number: 6130314
    Abstract: Novel peptides are provided having substantially the same sequence as immunologically significant fragments of AIDS-related viruses. The polypeptides can be used as reagents in the determination of exposure of a human host to the virus. Of particular interest is the use of polypeptides in screening blood products.
    Type: Grant
    Filed: May 18, 1994
    Date of Patent: October 10, 2000
    Assignee: Genetic Systems Corporation
    Inventor: Wesley Loren Cosand